… SARS-CoV-2-induced coronavirus disease-19 (COVID-19) has become one of the main …
immunological data on mechanisms associated with the SARS-CoV-2 infection and COVID-19 …

… frequent comorbidity among patients with COVID-19, 32 to date, asthma has not been
robustly considered a significant risk factor for developing severe COVID-19, 33 increased risk of …

… We will present clinical and immunological aspects that have to be considered with
regard to the COVID-19 pandemic in patients treated with biological therapy against IgE and …

… coronavirus 2 (SARS-CoV-2), was identified as the cause of the Coronavirus disease 2019
(COVID-19) … The European Academy of Allergy and Clinical Immunology (EAACI), but also …

… of an infectious disease defined as “Coronavirus disease 2019 (COVID-19)”. The COVID-19
pandemic is currently spreading around the globe. COVID-19 is caused by a novel strain of …

… to COVID-19 vaccination. Four SARS-CoV-2 vaccines are currently approved in the EU, and
their possible immunological … recommend an interval of ~ 1 week to COVID-19 vaccination. …

… , which may partly contribute to COVID-19-associated damage. … in patients with severe
COVID-19 seemed to positively impact … In summary, severely affected COVID-19 patients exhibit …

… COVID-19 control measures and increase our understanding of the immunology behind
COVID-19. … immunological tests for COVID-19 and provides recommendations for its application. …

… , 14 preventive measures, 10, 11, 15 and Position Statements elaborated by experts in the
field in close collaboration with the European Academy of Allergy and Clinical Immunology (…

… To fill some of these gaps in knowledge, a core COVID-19 Task Force of the European
Academy of … on neurological signs and symptoms observed in patients with COVID-19 infection. …